Treatment for Squamous Cell Carcinoma

Squamous cell carcinoma causes malignant cancer tumors in and around the skin, mouth, lungs, esophagus, vagina, urinary bladder, cervix and prostate. The malignancy is characteristic of differentiation of the squamous cell. Squamous cell carcinoma is either confined to the affected region or invades the underlying tissues. It is the latter that causes subsequent organ damage and metastasis. When the carcinoma is contained within a region, it is also clinically referred to as Bowen's disease.

SCC manifests in the following ways:

• Asymptomatic lesion.
• Slow development of an ulcer or skin plaque.
• Periodical bleeding of a lip tumor.
• Ulcerated lesions with raised edges.
• Development of hard plaque, with telangiectasia.
• Tumor at the back of the hand, lip, scalp and pinna surface, and other areas exposed to direct sunlight.
• Skin photodamage and solar keratoses.

Squamous cell carcinoma is a skin cancer that is not confined to any particular age, gender or genetics. Most of the time, the condition is diagnosed in people around 65 years of age. While Caucasians are more likely to develop squamous cell carcinoma, people with fair Celtic complexion and those regularly exposed to direct UV radiation are also at risk. There have also been instances where the consumption of arsenic in ground water increase the risk of squamous cell carcinoma. On and in the skin, the cancer has a high metastatic and rate of recurrence. In the mouth and surrounding region, the carcinoma is aggravated due to alcohol abuse and smoking. In the case of esophageal squamous cell carcinoma and adenocarcinomas, closer to the stomach region, the symptoms are aggravated with solid-food intake.

Treatment for Squamous Cell Carcinoma:

Squamous Cell Carcinoma can only be diagnosed via biopsy. Most of the time, biopsy requires tissue extract that is both subcutanous as well as basal. Excision biopsy and/or incisional biopsy are both offered alongside shave biopsy. The treatment options in the case of squamous cell carcinoma include surgery or topical medications, depending on the extent of cell mutation on clinical diagnosis of the condition.

Mohs surgery: This treatment option for squamous cell carcinoma is also referred to as chemosurgery. It is a microscopically controlled surgery technique, which involves accurate removal of the cancerous tissue. Mohs surgery is a frequently adopted plan of action.

Imiquimod: Imiquimod or Aldara is a topical application that is used in the case of in-situ squamous cell carcinoma. It is used to retain skin texture and reduce scars. Imiquimod is used in the treatment of both, basal cell carcinoma and squamous cell carcinoma. The treatment option activates the immune system through the receptor 7 and subsequently causes the release of the cytokines tumor necrosis factor α, interferon-α and interleukin-6. The application increases the secretion of the opioid growth factor receptor also clinically referred to as OGFr.

Afamelanotide: Afamelanotide is a melanocyte-stimulating hormone that is also used as an alternative cancer treatment to address the discomfort associated with squamous cell carcinoma. The main objective behind the use of this topical application is photoprotection in the case of organ transplant, to prevent skin and actinic keratosis. Afamelanotide helps the production of pigmentation and subsequently, offers exposed skin parts UV protection.

If neglected, the onslaught of squamous cell carcinoma could also result in the development of any of the following conditions:

• Erythroplasia.
• Low grade malignancy called Keratoacanthoma that develops on the skin. The condition is triggered within the pilo-sebaceous glands and requires microscopic analysis.
• Bowen's disease, a condition that is triggered die to over-exposure to direct UV rays of the sun.
• Marjolin's ulcer, a non-healing ulcer that develops around a burn wound.
• Melanoma or skin cancer.
• Basal Cell Carcinoma, a type of usually non-malignant skin cancer.